Search
S-adenosyl methionine (AdoMet, SAM, ademetionine)
Function:
- S-adenosylmethionine provides a methyl group in synthesis of:
a) phosphatidylcholine
b) 5-methylcytosine
Pharmacology:
- SAMe
Indications: (uses)
1) osteoarthritis*
2) rheumatoid arthritis
3) fibromyalgia
4) liver disease
5) migraines
6) depression [5,6]
7) insomnia
* Preliminary suggest SAM-e may be as beneficial as NSAIDs for treatment of osteoarthritis [3]
Contraindications:
- not effective for bipolar disorder
- not effective for hyperhomocysteinemia [4]
Dosage:
1) 400 mg PO BID
2) 800 mg PO BID (depression)
3) parenteral form used for depression [2]
4) discontinue >= 14 days prior to surgery [4]
Adverse effects:
1) generally well tolerated
2) primarily gastrointestinal distress
- nausea, vomiting, diarrhea [5]
3) insomnia [4]
4) dizziness [4]
5) xerostomia [4]
6) headache [4]
7) anxiety restlessness [4,5]
8) potential to cause agitation, mania, or hypomania via alterations in neurotransmitter levels
Drug interactions:
- antidepressants
- tricyclic antidepressants, SSRI [5]
- St John's wort
- antiplatelet agents including NSAIDs [4]
- anticoagulants
Mechanism of action:
1) increases plasma cortisol & ACTH
2) reduces plasma prolactin
3) increases catechol-O-methyltransferase (COMT) activity
4) inhibits MAO-B in the brain
5) enhances MAO activity in heart & brain
6) enhances proteoglycan production by chondrocytes
7) anti-inflammatory properties
8) analgesic properties
9) serotonin agonist
Interactions
molecular events
Related
carnitine biosynthesis
catecholamine metabolism
methionine adenosyltransferase, S-adenosylmethionine [SAM] synthetase or ADOMET synthetase
methionine metabolism (trans-sulfuration pathway)
S-adenosylmethionine (SAM) in serum/plasma
S-adenosylmethionine in body fluid
S-adenosylmethionine in CSF
S-adenosylmethionine in urine
S-adenosylmethionine/creatinine in urine
General
metabolic agent (metabolic modifier)
purine nucleoside
Properties
Database Correlations
PUBCHEM correlations
References
- Stryer Biochemistry WH Freeman & Co, New York, 1988 pg 582
- Geriatrics Review Syllabus, American Geriatrics Society,
5th edition, 2002-2004; 7th edition 2010
- Prescriber's Letter 10(5):27 2003
- Geriatrics at your Fingertips, 13th edition, 2011
Reuben DB et al (eds)
American Geriatric Society
- Geriatric Review Syllabus, 8th edition (GRS8)
Durso SC and Sullivan GN (eds)
American Geriatrics Society, 2013
- Geriatric Review Syllabus, 9th edition (GRS9)
Medinal-Walpole A, Pacala JT, Porter JF (eds)
American Geriatrics Society, 2016
- Alpert JE, Papakostas G, Mischoulon D et al
S-adenosyl-L-methionine (SAMe) as an adjunct for resistant
major depressive disorder: an open trial following partial or
nonresponse to selective serotonin reuptake inhibitors or
venlafaxine.
J Clin Psychopharmacol. 2004 Dec;24(6):661-4.
PMID: 15538131
Substructures
adenosine (Adenocard, Adenoscan)
methionine
Component-of
Flexium